Galmed Pharmaceuticals Ltd.

Nasdaq:GLMD

Pharmaceutical Preparations·RAMAT GAN, L3

Governanceproxy statements · beneficial ownership

Ownership Filings

33 shown

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
9/20/24	SC 13G/A	AMENDMENT NO. 1	→
9/20/24	SC 13G	SC 13G	→
2/14/24	SC 13G/A	SC 13G/A	→
2/14/24	SC 13G/A	AMENDMENT NO. 5 TO SCHEDULE 13G	→
2/12/24	SC 13G/A	SC 13G/A	→
↓